Detalles de la búsqueda
1.
Early recapture of response with tofacitinib 10 mg twice daily in patients with ulcerative colitis in OCTAVE Open following dose reduction or treatment interruption in OCTAVE Sustain.
J Gastroenterol Hepatol
; 39(2): 264-271, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37953548
2.
Improvements in Disease Activity Partially Mediate the Effect of Tofacitinib Treatment on Generic and Disease-Specific Health-Related Quality of Life in Patients with Ulcerative Colitis: Data from the OCTAVE Program.
Dig Dis
; 41(4): 604-614, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36603566
3.
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis.
Dig Dis Sci
; 68(6): 2624-2634, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36739367
4.
Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status.
Clin Gastroenterol Hepatol
; 20(3): 591-601.e8, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33684552
5.
Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(1): 116-125.e5, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33039585
6.
Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis.
BMC Gastroenterol
; 22(1): 177, 2022 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35397501
7.
Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis.
Dig Dis
; 40(5): 553-564, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34879378
8.
Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 18(1): 123-132.e3, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31077827
9.
The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe.
BMC Gastroenterol
; 20(1): 18, 2020 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31964359
10.
Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis.
BMC Gastroenterol
; 22(1): 356, 2022 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35883049
11.
Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program.
Therap Adv Gastroenterol
; 16: 17562848231189122, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37560161
12.
Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program.
Patient
; 16(2): 95-103, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36336750
13.
Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program.
Inflamm Bowel Dis
; 29(5): 744-751, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35792493
14.
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program.
Inflamm Bowel Dis
; 29(1): 27-41, 2023 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36342120
15.
Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies.
Inflamm Bowel Dis
; 27(7): 983-993, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32794567
16.
Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
Inflamm Bowel Dis
; 27(6): 797-808, 2021 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32870265
17.
Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials.
Aliment Pharmacol Ther
; 54(11-12): 1442-1453, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34614208
18.
Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials.
J Crohns Colitis
; 15(11): 1852-1863, 2021 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33884415
19.
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme.
J Crohns Colitis
; 15(6): 914-929, 2021 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33245746
20.
Review of the epidemiology and burden of ulcerative colitis in Latin America.
Therap Adv Gastroenterol
; 13: 1756284820931739, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32695230